Simultaneous Determination of Bioactive Monoterpene Indole Alkaloids in Ethanolic Extract of Seven Rauvolfia Species Using UHPLC with Hybrid Triple Quadrupole Linear Ion Trap Mass Spectrometry
Overview
Authors
Affiliations
Introduction: Rauvolfia serpentina is an endangered plant species due to its over-exploitation. It has highly commercial and economic importance due to the presence of bioactive monoterpene indole alkaloids (MIAs) such as ajmaline, yohimbine, ajmalicine, serpentine and reserpine.
Objective: To develop a validated, rapid, sensitive and selective ultra-high-performance liquid chromatography coupled with hybrid triple quadrupole-linear ion trap mass spectrometry (UHPLC-QqQLIT -MS/MS) method in the multiple reaction monitoring (MRM) mode for simultaneous determination of bioactive MIAs in ethanolic extract of seven Rauvolfia species and herbal formulations.
Methods: The separation of MIAs was achieved on an ACQUITY UPLC BEH™ C18 column (1.7 μm, 2.1 mm × 50 mm) using a gradient mobile phase (0.1% aqueous formic acid and acetonitrile) at flow rate 0.3 μL/min in 7 min. The validated method showed good linearity (r(2) ≥ 0.9999), limit of detection (LOD) (0.06-0.15 ng/mL), limit of quantitation (LOQ) (0.18-0.44 ng/mL), precisions [intraday: relative standard deviation (RSD) ≤ 2.24%, interday: RSD ≤ 2.74%], stability (RSD ≤ 1.53%) and overall recovery (RSD ≤ 2.23%).
Results: The validated method was applied to quantitate MIAs. Root of Rauvolfia vomitoria showed a high content of ajmaline (48.43 mg/g), serpentine (87.77 mg/g) whereas high quantities of yohimbine (100.21 mg/g) and ajmalicine (120.51 mg/g) were detected in R. tetraphylla. High content of reserpine was detected in R. micrantha (35.18 mg/g) and R. serpentina (32.38 mg/g).
Conclusion: The encouraging results of this study may lead to easy selection of suitable Rauvolfia species according to the abundance of MIAs. Copyright © 2016 John Wiley & Sons, Ltd.
Autophagy in benign prostatic hyperplasia: insights and therapeutic potential.
Zhou X, Huang P, Wu Y, Yu J, Sun J BMC Urol. 2024; 24(1):198.
PMID: 39261818 PMC: 11391623. DOI: 10.1186/s12894-024-01585-7.
Lezin E, Carqueijeiro I, Cuello C, Durand M, Jansen H, Verges V Plant Commun. 2023; 5(4):100784.
PMID: 38155576 PMC: 11009098. DOI: 10.1016/j.xplc.2023.100784.
Developments in biotechnological tools and techniques for production of reserpine.
Swain H, Gantait S, Mandal N Appl Microbiol Biotechnol. 2023; 107(13):4153-4164.
PMID: 37212883 DOI: 10.1007/s00253-023-12570-9.
Huang G, He X, Xue Z, Long Y, Liu J, Cai J BMC Complement Med Ther. 2022; 22(1):125.
PMID: 35513857 PMC: 9074266. DOI: 10.1186/s12906-022-03610-4.
Mohammed A, Abdul-Hameed Z, Alotaibi M, Bawakid N, Sobahi T, Abdel-Lateff A Molecules. 2021; 26(2).
PMID: 33477682 PMC: 7831967. DOI: 10.3390/molecules26020488.